BBNX Insider Trading Activity and SEC Form 4 Filings
BBNX insider trading summary
Over the past 12 months, insiders at Beta Bionics, Inc. (BBNX) reported 48 sales worth $4.6M by 8 insiders and no open-market purchases on SEC Form 4. Net insider selling was $4.6M.
Latest BBNX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 2, 2026 | Mark Hopman | Chief Commercial Officer | Sell | $6K (370 @ $16.90) |
| Oct 27, 2026 | Mike Mensinger | Chief Product Officer | Sell | $58K (2,650 @ $22.00) |
| Oct 26, 2026 | Mark Hopman | Chief Commercial Officer | Sell | $16K (821 @ $20.00) |
| Oct 14, 2026 | Mark Hopman | Chief Commercial Officer | Sell | $13K (775 @ $17.35) |
| Oct 1, 2026 | Mark Hopman | Chief Commercial Officer | Sell | $7K (370 @ $18.96) |
| Sep 22, 2026 | Christy Jones | Insider | Sell | $148K (6,430 @ $23.00) |
| Sep 16, 2026 | Mike Mensinger | Chief Product Officer | Sell | $58K (2,650 @ $22.00) |
| Sep 16, 2026 | Mark Hopman | Chief Commercial Officer | Sell | $620K (30,779 @ $20.13) |
| Sep 14, 2026 | Mark Hopman | Chief Commercial Officer | Sell | $12K (775 @ $15.52) |
| Sep 9, 2026 | Mark Hopman | Chief Commercial Officer | Sell | $665K (35,994 @ $18.46) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.